Identifying maternal self-reported alcohol use associated with Fetal Alcohol Spectrum Disorders

被引:116
作者
Barr, HM [1 ]
Streissguth, AP [1 ]
机构
[1] Univ Washington, Dept Psychiat & Behav Sci, Fetal Alcohol & Drug Unit, Seattle, WA 98195 USA
关键词
prenatal alcohol exposure; pregnancy risk; fetal alcohol syndrome; fetal alcohol effects; screening;
D O I
10.1111/j.1530-0277.2001.tb02210.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The incidence of Fetal Alcohol Syndrome (FAS) has been estimated at 1 to 3 per 1000 live births. Fetal Alcohol Spectrum Disorders (FASD) (which include FAS) are estimated to occur in about 1 in 100 births. Cessation of drinking during pregnancy can improve the outcome even if the unborn child is already affected. For individuals born with FASD, an early diagnosis appears to be a protective factor against secondary disabilities. A quick screening tool to identify newborn children at risk has been elusive. Methods: A simple descriptive presentation is offered that shows where 36 individuals with FASD were found from among the many patterns and amounts of prenatal alcohol use that were reported by a sample of 1439 pregnant women whose offspring were later examined within the first 7 years of life. Results: Individuals with FASD (i.e., those with FAS, fetal alcohol effects, alcohol-related neurodevelopmental disorder)were found within two aggregates of alcohol scores that together recommend a set of three to four alcohol questions. Within this derivation sample, one scoring of the questions yields almost 78% sensitivity and 97% specificity for FASD. Another scoring of the same instrument yields 100% sensitivity with 90% specificity. Conclusions: These new data may facilitate early identification of offspring who may be most in need of early intervention, namely those born with FASD.
引用
收藏
页码:283 / 287
页数:5
相关论文
共 28 条
[1]  
Cahalan D, 1969, MONOGRAPH RUTGERS CT, V6
[2]  
*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P349
[3]   FACIAL EFFECTS OF FETAL ALCOHOL EXPOSURE - ASSESSMENT BY PHOTOGRAPHS AND MORPHOMETRIC ANALYSIS [J].
CLARREN, SK ;
SAMPSON, PD ;
LARSEN, J ;
DONNELL, DJ ;
BARR, HM ;
BOOKSTEIN, FL ;
MARTIN, DC ;
STREISSGUTH, AP .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 26 (03) :651-666
[4]  
*FOOD DRUG ADM, 1981, FDA DRUG B, V11, P9
[5]  
GRAHAM JM, 1988, PEDIATRICS, V81, P772
[6]   Pregnant, alcohol-abusing women [J].
Hankin, J ;
McCaul, ME ;
Heussner, J .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (08) :1276-1286
[7]   IDENTIFICATION AND CARE OF PROBLEMS ASSOCIATED WITH ALCOHOL INGESTION IN PREGNANCY [J].
HANKIN, JR ;
SOKOL, RJ .
SEMINARS IN PERINATOLOGY, 1995, 19 (04) :286-292
[8]   EFFECTS OF MODERATE ALCOHOL CONSUMPTION DURING PREGNANCY ON FETAL GROWTH AND MORPHOGENESIS [J].
HANSON, JW ;
STREISSGUTH, AP ;
SMITH, DW .
JOURNAL OF PEDIATRICS, 1978, 92 (03) :457-460
[9]   TERATOGENIC EFFECTS OF ALCOHOL ON INFANT DEVELOPMENT [J].
JACOBSON, JL ;
JACOBSON, SW ;
SOKOL, RJ ;
MARTIER, SS ;
AGER, JW ;
KAPLANESTRIN, MG .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1993, 17 (01) :174-183
[10]   Relation of maternal age and pattern of pregnancy drinking to functionally significant cognitive deficit in infancy [J].
Jacobson, JL ;
Jacobson, SW ;
Sokol, RJ ;
Ager, JW .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (02) :345-351